The Korean journal of internal medicine

  • 제33권2호
  • /
  • Pages.233-246
  • /
  • 2018
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea

  • Oh, Myoung-don (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Park, Wan Beom (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Park, Sang-Won (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Choe, Pyoeng Gyun (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Bang, Ji Hwan (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Song, Kyoung-Ho (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Kim, Eu Suk (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Kim, Hong Bin (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Kim, Nam Joong (Department of Internal Medicine, Seoul National University College of Medicine)
  • 투고 : 2018.02.05
  • 심사 : 2018.02.13
  • 발행 : 2018.03.01
⟨ 이전 논문 다음 논문 ⟩

초록

Middle East Respiratory Syndrome coronavirus (MERS-CoV) was first isolated from a patient with severe pneumonia in 2012. The 2015 Korea outbreak of MERSCoV involved 186 cases, including 38 fatalities. A total of 83% of transmission events were due to five superspreaders, and 44% of the 186 MERS cases were the patients who had been exposed in nosocomial transmission at 16 hospitals. The epidemic lasted for 2 months and the government quarantined 16,993 individuals for 14 days to control the outbreak. This outbreak provides a unique opportunity to fill the gap in our knowledge of MERS-CoV infection. Therefore, in this paper, we review the literature on epidemiology, virology, clinical features, and prevention of MERS-CoV, which were acquired from the 2015 Korea outbreak of MERSCoV.

키워드

참고문헌

  1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367:1814-1820. https://doi.org/10.1056/NEJMoa1211721
  2. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) [Internet]. Geneva: World Health Organization, c2018 [cited 2018 Feb 8]. Available from: http://who.int/emergencies/mers-cov/en/.
  3. Ministry of Health Kingdom of Saudi Arabia. MERSCoV daily update [Internet]. Riyadh (SA): Ministry of Health Kingdom of Saudi Arabia, c2014 [cited 2018 Feb 8]. Available from: https://www.moh.gov.sa/en/CCC/ PressReleases/Pages/statistics-2018-01-27-001.aspx.
  4. Arabi YM, Balkhy HH, Hayden FG, et al. Middle East respiratory syndrome. N Engl J Med 2017;376:584-594. https://doi.org/10.1056/NEJMsr1408795
  5. Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018 In Press.
  6. Public Health England. Treatment of MERS-CoV: information for clinicians. Clinical decision-making support for treatment of MERS-CoV patients [Internet]. London (UK): Public Health England, 2017 [cited 2018 Feb 8]. Available from: https://www.gov.uk/government/ uploads/system/uploads/attachment_data/file/638628/ MERS_CoV_guidance_for_clinicians.pdf.
  7. Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect 2015;6:269-278. https://doi.org/10.1016/j.phrp.2015.08.006
  8. Oh MD. The Korean Middle East respiratory syndrome coronavirus outbreak and our responsibility to the global scientific community. Infect Chemother 2016;48:145-146. https://doi.org/10.3947/ic.2016.48.2.145
  9. Lee JY, Kim YJ, Chung EH, et al. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis 2017;17:498. https://doi.org/10.1186/s12879-017-2576-5
  10. Kim KM, Ki M, Cho SI, et al. Epidemiologic features of the first MERS outbreak in Korea: focus on Pyeongtaek St. Mary's Hospital. Epidemiol Health 2015;37:e2015041. https://doi.org/10.4178/epih/e2015041
  11. Yang JS, Park S, Kim YJ, et al. Middle East respiratory syndrome in 3 persons, South Korea, 2015. Emerg Infect Dis 2015;21:2084-2087. https://doi.org/10.3201/eid2111.151016
  12. Park YS, Lee C, Kim KM, et al. The first case of the 2015 Korean Middle East respiratory syndrome outbreak. Epidemiol Health 2015;37:e2015049. https://doi.org/10.4178/epih/e2015049
  13. FluTrackers. South Korea coronavirus MERS case list: including imported and exported cases. Ministry of Health & WHO confirmed data only: 2015 outbreak [Internet]. Winter Park (FL): FluTrackers, c2018 [cited 2018 Feb 8]. Available from: https://flutrackers.com/forum/forum/novelcoronavirus- ncov-mers-2012-2014/novel-coronavirus-whochp- wpro-ecdc-oie-fao-moa-reports-and-updates/southkorea- coronavirus/732065-south-korea-coronavirus-merscase- list-including-imported-and-exported-cases-ministryof- health-who-confirmed-data-only-2015-outbreak.
  14. Korea Broadcasting System Digital News. MERS-CoV infection: current status-interactive and infographics [Internet]. KBS Digital News, c2013 [cited 2018 Feb 8]. Available from: http://dj.kbs.co.kr/resources/2015-06-08/.
  15. Lee SS, Wong NS. Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea. Int J Infect Dis 2015;38:65-67. https://doi.org/10.1016/j.ijid.2015.07.014
  16. Kim KH, Tandi TE, Choi JW, Moon JM, Kim MS. Middle East respiratory syndrome coronavirus (MERSCoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect 2017;95:207-213. https://doi.org/10.1016/j.jhin.2016.10.008
  17. Ministry of Health and Welfare. The 2015 MERS outbreak in the Republic of Korea: learning from MERS (The White Paper). Seoul (KR): Ministry of Health and Welfare, 2016:473.
  18. Xiao S, Li Y, Sung M, Wei J, Yang Z. A study of the probable transmission routes of MERS-CoV during the first hospital outbreak in the Republic of Korea. Indoor Air 2018;28:51-63. https://doi.org/10.1111/ina.12430
  19. Oh MD, Choe PG, Oh HS, et al. Middle East respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015. J Korean Med Sci 2015;30:1701-1705. https://doi.org/10.3346/jkms.2015.30.11.1701
  20. Cho SY, Kang JM, Ha YE, et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 2016;388:994-1001. https://doi.org/10.1016/S0140-6736(16)30623-7
  21. Park GE, Ko JH, Peck KR, et al. Control of an outbreak of Middle East respiratory syndrome in a tertiary hospital in Korea. Ann Intern Med 2016;165:87-93. https://doi.org/10.7326/M15-2495
  22. Park SH, Kim YS, Jung Y, et al. Outbreaks of Middle East respiratory syndrome in two hospitals initiated by a single patient in Daejeon, South Korea. Infect Chemother 2016;48:99-107. https://doi.org/10.3947/ic.2016.48.2.99
  23. Park JW, Lee KJ, Lee KH, et al. Hospital outbreaks of Middle East respiratory syndrome, Daejeon, South Korea, 2015. Emerg Infect Dis 2017;23:898-905. https://doi.org/10.3201/eid2306.160120
  24. Nam HS, Park JW, Ki M, Yeon MY, Kim J, Kim SW. High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea. Int J Infect Dis 2017;58:37-42. https://doi.org/10.1016/j.ijid.2017.02.008
  25. Wu J, Yi L, Zou L, Zhong H, et al. Imported case of MERSCoV infection identified in China, May 2015: detection and lesson learned. Euro Surveill 2015;20:21158. https://doi.org/10.2807/1560-7917.ES2015.20.24.21158
  26. Wang Y, Liu D, Shi W, et al. Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in china: phylogenetics and coalescence analysis. MBio 2015;6:e01280-15.
  27. Kang CK, Song KH, Choe PG, et al. Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 outbreak in Korea. J Korean Med Sci 2017;32:744-749. https://doi.org/10.3346/jkms.2017.32.5.744
  28. Park SH, Kim WJ, Yoo JH, Choi JH. Epidemiologic parameters of the Middle East respiratory syndrome outbreak in Korea, 2015. Infect Chemother 2016;48:108-117. https://doi.org/10.3947/ic.2016.48.2.108
  29. Park HY, Lee EJ, Ryu YW, et al. Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill 2015;20:1-6.
  30. Chowell G, Abdirizak F, Lee S, et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med 2015;13:210. https://doi.org/10.1186/s12916-015-0450-0
  31. Chun BC. Understanding and modeling the super-spreading events of the Middle East respiratory syndrome outbreak in Korea. Infect Chemother 2016;48:147-149. https://doi.org/10.3947/ic.2016.48.2.147
  32. Ki M. 2015 MERS outbreak in Korea: hospital-to-hospital transmission. Epidemiol Health 2015;37:e2015033. https://doi.org/10.4178/epih/e2015033
  33. Nishiura H, Endo A, Saitoh M, et al. Identifying determinants of heterogeneous transmission dynamics of the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea, 2015: a retrospective epidemiological analysis. BMJ Open 2016;6:e009936. https://doi.org/10.1136/bmjopen-2015-009936
  34. Virlogeux V, Fang VJ, Park M, Wu JT, Cowling BJ. Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci Rep 2016;6:35839. https://doi.org/10.1038/srep35839
  35. Zhang XS, Pebody R, Charlett A, et al. Estimating and modelling the transmissibility of Middle East respiratory syndrome coronavirus during the 2015 outbreak in the Republic of Korea. Influenza Other Respir Viruses 2017;11:434-444. https://doi.org/10.1111/irv.12467
  36. Choi S, Jung E, Choi BY, Hur YJ, Ki M. High reproduction number of Middle East respiratory syndrome coronavirus in nosocomial outbreaks: mathematical modelling in Saudi Arabia and South Korea. J Hosp Infect 2017 Sep 25 [Epub]. https://doi.org/10.1016/j.jhin.2017.09.017.
  37. Kucharski AJ, Althaus CL. The role of superspreading in Middle East respiratory syndrome coronavirus (MERSCoV) transmission. Euro Surveill 2015;20:14-18.
  38. Kim SW, Park JW, Jung HD, et al. Risk factors for transmission of Middle East respiratory syndrome coronavirus infection during the 2015 outbreak in South Korea. Clin Infect Dis 2017;64:551-557.
  39. Kim T, Jung J, Kim SM, et al. Transmission among healthcare worker contacts with a Middle East respiratory syndrome patient in a single Korean centre. Clin Microbiol Infect 2016;22:e11-e13. https://doi.org/10.1016/j.cmi.2015.09.007
  40. Kim YJ, Cho YJ, Kim DW, et al. Complete genome sequence of Middle East respiratory syndrome coronavirus KOR/KNIH/002_05_2015, isolated in South Korea. Genome Announc 2015;3:e00787-15.
  41. Lu R, Wang Y, Wang W, et al. Complete genome sequence of Middle East Respiratory syndrome coronavirus (MERS-CoV) from the first imported MERS-CoV case in China. Genome Announc 2015;3:e00818-15.
  42. Park WB, Kwon NJ, Choe PG, et al. Isolation of Middle East respiratory syndrome coronavirus from a patient of the 2015 Korean outbreak. J Korean Med Sci 2016;31:315-320. https://doi.org/10.3346/jkms.2016.31.2.315
  43. Seong MW, Kim SY, Corman VM, et al. Microevolution of outbreak-associated Middle East respiratory syndrome coronavirus, South Korea, 2015. Emerg Infect Dis 2016;22:327-330.
  44. Sabir JS, Lam TT, Ahmed MM, et al. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science 2016;351:81-84. https://doi.org/10.1126/science.aac8608
  45. Kim JI, Kim YJ, Lemey P, et al. The recent ancestry of Middle East respiratory syndrome coronavirus in Korea has been shaped by recombination. Sci Rep 2016;6:18825. https://doi.org/10.1038/srep18825
  46. Kim DW, Kim YJ, Park SH, et al. Variations in spike glycoprotein gene of MERS-CoV, South Korea, 2015. Emerg Infect Dis 2016;22:100-104. https://doi.org/10.3201/eid2201.151055
  47. Kim Y, Cheon S, Min CK, et al. Spread of mutant Middle East respiratory syndrome coronavirus with reduced affinity to human CD26 during the South Korean outbreak. MBio 2016;7:e00019.
  48. Park D, Huh HJ, Kim YJ, et al. Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus. Cold Spring Harb Mol Case Stud 2016;2:a001214.
  49. Xie Q, Cao Y, Su J, et al. Two deletion variants of Middle East respiratory syndrome coronavirus found in a patient with characteristic symptoms. Arch Virol 2017;162:2445-2449. https://doi.org/10.1007/s00705-017-3361-x
  50. Oh MD, Park WB, Choe PG, et al. Viral load kinetics of MERS coronavirus infection. N Engl J Med 2016;375:1303-1305. https://doi.org/10.1056/NEJMc1511695
  51. Min CK, Cheon S, Ha NY, et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep 2016;6:25359. https://doi.org/10.1038/srep25359
  52. Park WB, Perera RA, Choe PG, et al. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea. Emerg Infect Dis 2015;21:2186-2189. https://doi.org/10.3201/eid2112.151421
  53. Ko JH, Muller MA, Seok H, et al. Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity. Diagn Microbiol Infect Dis 2017;89:106-111. https://doi.org/10.1016/j.diagmicrobio.2017.07.006
  54. Choe PG, Perera RAPM, Park WB, et al. MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015. Emerg Infect Dis 2017;23:1079-1084.
  55. Choi WS, Kang CI, Kim Y, et al. Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea. Infect Chemother 2016;48:118-126. https://doi.org/10.3947/ic.2016.48.2.118
  56. Rhee JY, Hong G, Ryu KM. Clinical implications of 5 cases of Middle East respiratory syndrome coronavirus infection in a South Korean outbreak. Jpn J Infect Dis 2016;69:361-366. https://doi.org/10.7883/yoken.JJID.2015.445
  57. Kim ES, Choe PG, Park WB, et al. Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection. J Korean Med Sci 2016;31:1717-1725. https://doi.org/10.3346/jkms.2016.31.11.1717
  58. Ko JH, Park GE, Lee JY, et al. Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients. J Infect 2016;73:468-475. https://doi.org/10.1016/j.jinf.2016.08.005
  59. Cha RH, Joh JS, Jeong I, et al. Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-CoV designated hospital. J Korean Med Sci 2015;30:1807-1814. https://doi.org/10.3346/jkms.2015.30.12.1807
  60. Kim JE, Heo JH, Kim HO, et al. Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol 2017;13:227-233. https://doi.org/10.3988/jcn.2017.13.3.227
  61. Choi WJ, Lee KN, Kang EJ, Lee H. Middle East respiratory syndrome-coronavirus infection: a case report of serial computed tomographic findings in a young male patient. Korean J Radiol 2016;17:166-170. https://doi.org/10.3348/kjr.2016.17.1.166
  62. Park GE, Kang CI, Ko JH, et al. Differential cell count and CRP level in blood as predictors for Middle East respiratory syndrome coronavirus infection in acute febrile patients during nosocomial outbreak. J Korean Med Sci 2017;32:151-154. https://doi.org/10.3346/jkms.2017.32.1.151
  63. Lee H, Ki CS, Sung H, et al. Guidelines for the laboratory diagnosis of Middle East respiratory syndrome coronavirus in Korea. Infect Chemother 2016;48:61-69. https://doi.org/10.3947/ic.2016.48.1.61
  64. Ki CS, Lee H, Sung H, et al. Korean Society for Laboratory Medicine practice guidelines for the molecular diagnosis of Middle East respiratory syndrome during an outbreak in Korea in 2015. Ann Lab Med 2016;36:203-208. https://doi.org/10.3343/alm.2016.36.3.203
  65. Huh HJ, Ko JH, Kim YE, et al. Importance of specimen type and quality in diagnosing Middle East respiratory syndrome. Ann Lab Med 2017;37:81-83. https://doi.org/10.3343/alm.2017.37.1.81
  66. Lee JH, Lee CS, Lee HB. An appropriate lower respiratory tract specimen is essential for diagnosis of Middle East respiratory syndrome (MERS). J Korean Med Sci 2015;30:1207-1208. https://doi.org/10.3346/jkms.2015.30.8.1207
  67. Kim SH, Ko JH, Park GE, et al. Atypical presentations of MERS-CoV infection in immunocompromised hosts. J Infect Chemother 2017;23:769-773. https://doi.org/10.1016/j.jiac.2017.04.004
  68. Chong YP, Song JY, Seo YB, Choi JP, Shin HS; Rapid Response Team. Antiviral treatment guidelines for Middle East respiratory syndrome. Infect Chemother 2015;47:212-222. https://doi.org/10.3947/ic.2015.47.3.212
  69. Hong KH, Choi JP, Hong SH, et al. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax 2018;73:286-289. https://doi.org/10.1136/thoraxjnl-2016-209313
  70. Majumder MS, Kluberg SA, Mekaru SR, Brownstein JS. Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015. Emerg Infect Dis 2015;21:2088-2090. https://doi.org/10.3201/eid2111.151231
  71. Mizumoto K, Endo A, Chowell G, Miyamatsu Y, Saitoh M, Nishiura H. Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015. BMC Med 2015;13:228. https://doi.org/10.1186/s12916-015-0468-3
  72. Kim SY, Park SJ, Cho SY, et al. Viral RNA in blood as indicator of severe outcome in Middle East respiratory syndrome coronavirus infection. Emerg Infect Dis 2016;22:1813-1816. https://doi.org/10.3201/eid2210.160218
  73. Virlogeux V, Park M, Wu JT, Cowling BJ. Association between severity of MERS-CoV infection and incubation period. Emerg Infect Dis 2016;22:526-528. https://doi.org/10.3201/eid2203.151437
  74. Jeong SY, Sung SI, Sung JH, et al. MERS-CoV infection in a pregnant woman in Korea. J Korean Med Sci 2017;32:1717-1720. https://doi.org/10.3346/jkms.2017.32.10.1717
  75. Kim I, Lee JE, Kim KH, Lee S, Lee K, Mok JH. Successful treatment of suspected organizing pneumonia in a patient with Middle East respiratory syndrome coronavirus infection: a case report. J Thorac Dis 2016;8:E1190-E1194. https://doi.org/10.21037/jtd.2016.09.26
  76. Jeong H, Yim HW, Song YJ, et al. Mental health status of people isolated due to Middle East respiratory syndrome. Epidemiol Health 2016;38:e2016048. https://doi.org/10.4178/epih.e2016048
  77. Chun S, Chung CR, Ha YE, et al. Possible transfusionrelated acute lung injury following convalescent plasma transfusion in a patient with Middle East respiratory syndrome. Ann Lab Med 2016;36:393-395. https://doi.org/10.3343/alm.2016.36.4.393
  78. Kim JY, Song JY, Yoon YK, et al. Middle East respiratory syndrome infection control and prevention guideline for healthcare facilities. Infect Chemother 2015;47:278-302. https://doi.org/10.3947/ic.2015.47.4.278
  79. Moon SY, Son JS, Lee YH, et al. Middle East respiratory syndrome coronavirus transmission in dialysis unit and infection control interventions in Korea. Infect Control Hosp Epidemiol 2016;37:1514-1516. https://doi.org/10.1017/ice.2016.201
  80. Park HC, Lee YK, Lee SH, et al. Middle East respiratory syndrome clinical practice guideline for hemodialysis facilities. Kidney Res Clin Pract 2017;36:111-116. https://doi.org/10.23876/j.krcp.2017.36.2.111
  81. van Doremalen N, Bushmaker T, Munster VJ. Stability of Middle East respiratory syndrome coronavirus (MERS CoV) under different environmental conditions. Euro Surveill 2013;18:20590. https://doi.org/10.2807/1560-7917.ES2013.18.38.20590
  82. Bin SY, Heo JY, Song MS, et al. Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea. Clin Infect Dis 2016;62:755-760. https://doi.org/10.1093/cid/civ1020
  83. Oh MD. Environmental contamination and viral shedding in MERS patients. Clin Infect Dis 2016;62:1615.
  84. Song JY, Cheong HJ, Choi MJ, et al. Viral shedding and environmental cleaning in Middle East respiratory syndrome coronavirus infection. Infect Chemother 2015;47:252-255. https://doi.org/10.3947/ic.2015.47.4.252
  85. Kim SH, Chang SY, Sung M, et al. Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards. Clin Infect Dis 2016;63:363-369. https://doi.org/10.1093/cid/ciw239
  86. Oh MD. Transmissibility of Middle East respiratory syndrome by the airborne route. Clin Infect Dis 2016;63:1143.
  87. Majumder MS, Brownstein JS, Finkelstein SN, Larson RC, Bourouiba L. Nosocomial amplification of MERScoronavirus in South Korea, 2015. Trans R Soc Trop Med Hyg 2017;111:261-269. https://doi.org/10.1093/trstmh/trx046
  88. Nam HS, Yeon MY, Park JW, Hong JY, Son JW. Healthcare worker infected with Middle East Respiratory Syndrome during cardiopulmonary resuscitation in Korea, 2015. Epidemiol Health 2017;39:e2017052. https://doi.org/10.4178/epih.e2017052
  89. Kim CJ, Choi WS, Jung Y, et al. Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity. Clin Microbiol Infect 2016;22:880-886. https://doi.org/10.1016/j.cmi.2016.07.017
  90. Lee JY, Kim G, Lim DG, et al. Seroprevalence of Middle East respiratory syndrome coronavirus among healthcare personnel caring for patients with middle east respiratory syndrome in South Korea. Infect Control Hosp Epidemiol 2016;37:1513-1514. https://doi.org/10.1017/ice.2016.221
  91. Ko JH, Lee JY, Baek JY, et al. Serologic evaluation of MERS screening strategy for healthcare personnel during a hospital-associated outbreak. Infect Control Hosp Epidemiol 2017;38:234-238. https://doi.org/10.1017/ice.2016.251
  92. Moon SY, Son JS, Lee YH, et al. Middle East respiratory syndrome coronavirus transmission in dialysis unit and infection control interventions in Korea. Infect Control Hosp Epidemiol 2016;37:1514-1516. https://doi.org/10.1017/ice.2016.201
  93. World Health Organization. Management of asymptomatic persons who are RT-PCR positive for Middle East respiratory syndrome coronavirus (MERS-CoV): Interim guidance [Internet]. Geneva: World Health Organization, c2018 [cited 2018 Feb 8]. Available from: http://apps.who.int/ iris/bitstream/10665/180973/1/WHO_MERS_IPC_15.2_eng. pdf?ua=1&ua=1.
  94. Lee J; Rapid Response Team, Kim WJ. Collaborative intervention of Middle East respiratory syndrome: rapid response team. Infect Chemother 2016;48:71-74. https://doi.org/10.3947/ic.2016.48.2.71
  95. Jeon MH, Kim TH. Institutional preparedness to prevent future Middle East respiratory syndrome coronaviruslike outbreaks in Republic of Korea. Infect Chemother 2016;48:75-80. https://doi.org/10.3947/ic.2016.48.2.75

피인용 문헌

  1. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein vol.8, pp.None, 2018, https://doi.org/10.1038/s41598-018-34859-w
  2. Airflow as a Possible Transmission Route of Middle East Respiratory Syndrome at an Initial Outbreak Hospital in Korea vol.15, pp.12, 2018, https://doi.org/10.3390/ijerph15122757
  3. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization vol.93, pp.2, 2019, https://doi.org/10.1128/jvi.01381-18
  4. Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections vol.10, pp.None, 2019, https://doi.org/10.3389/fmicb.2019.00569
  5. Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea vol.6, pp.3, 2018, https://doi.org/10.1098/rsos.181164
  6. Transmission and prevention of acute viral respiratory tract infections in hospitals vol.25, pp.3, 2018, https://doi.org/10.1097/mcp.0000000000000566
  7. Preventive Behavioral Responses to the 2015 Middle East Respiratory Syndrome Coronavirus Outbreak in Korea vol.16, pp.12, 2018, https://doi.org/10.3390/ijerph16122161
  8. Verification and diagnostic evaluation of the RealStar ® Middle East respiratory syndrome coronavirus (N gene) reverse transcription-PCR kit 1.0 vol.14, pp.11, 2018, https://doi.org/10.2217/fmb-2019-0067
  9. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial vol.19, pp.9, 2019, https://doi.org/10.1016/s1473-3099(19)30266-x
  10. Impact of crisis events on Chinese outbound tourist flow: A framework for post-events growth vol.74, pp.None, 2019, https://doi.org/10.1016/j.tourman.2019.04.011
  11. Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody vol.20, pp.20, 2018, https://doi.org/10.3390/ijms20205073
  12. Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens vol.15, pp.10, 2018, https://doi.org/10.1080/21645515.2019.1649532
  13. Improved survival rates in patients with H1N1 acute respiratory failure in Korea between 2009 and 2016 vol.14, pp.10, 2018, https://doi.org/10.1371/journal.pone.0223323
  14. 간호대학생의 신종 감염병에 대한 인식, 신종 감염병 상황에서의 윤리 인식과 윤리적 의사결정 vol.33, pp.3, 2018, https://doi.org/10.5932/jkphn.2019.33.3.326
  15. Repurposing and reshaping of hospitals during the COVID-19 outbreak in South Korea vol.10, pp.None, 2020, https://doi.org/10.1016/j.onehlt.2020.100137
  16. Coronavirus Infections in Children Including COVID-19 : An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children vol.39, pp.5, 2018, https://doi.org/10.1097/inf.0000000000002660
  17. Considerations for future novel human-infecting coronavirus outbreaks vol.11, pp.None, 2018, https://doi.org/10.25259/sni_191_2020
  18. National Response to COVID-19 in the Republic of Korea and Lessons Learned for Other Countries vol.6, pp.1, 2018, https://doi.org/10.1080/23288604.2020.1753464
  19. Active Targeted Surveillance to Identify Sites of Emergence of Hantavirus vol.70, pp.3, 2018, https://doi.org/10.1093/cid/ciz234
  20. Steering the Private Sector in COVID-19 Diagnostic Test Kit Development in South Korea vol.8, pp.None, 2018, https://doi.org/10.3389/fpubh.2020.563525
  21. Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections vol.12, pp.2, 2018, https://doi.org/10.3390/v12020194
  22. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study vol.395, pp.10225, 2020, https://doi.org/10.1016/s0140-6736(20)30260-9
  23. Middle East respiratory syndrome vol.395, pp.10229, 2018, https://doi.org/10.1016/s0140-6736(19)33221-0
  24. Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China vol.92, pp.4, 2020, https://doi.org/10.1002/jmv.25689
  25. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19) vol.63, pp.4, 2018, https://doi.org/10.3345/cep.2020.00493
  26. 코로나바이러스감염증-19의 바이러스 (SARS-CoV-2) 특징, 전파 및 임상 양상 vol.27, pp.1, 2020, https://doi.org/10.14776/piv.2020.27.e9
  27. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China vol.26, pp.4, 2018, https://doi.org/10.1038/s41591-020-0822-7
  28. Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus vol.15, pp.5, 2020, https://doi.org/10.1371/journal.pone.0232757
  29. Revised Triage and Surveillance Protocols for Temporary Emergency Department Closures in Tertiary Hospitals as a Response to COVID-19 Crisis in Daegu Metropolitan City vol.35, pp.19, 2018, https://doi.org/10.3346/jkms.2020.35.e189
  30. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge vol.21, pp.None, 2018, https://doi.org/10.1016/j.jgar.2020.02.021
  31. Case Study of Middle East Respiratory Syndrome (MERS-CoV) Outbreak in South Korea and Future Implications vol.10, pp.2, 2018, https://doi.org/10.4236/aid.2020.102007
  32. A novel cohort analysis approach to determining the case fatality rate of COVID-19 and other infectious diseases vol.15, pp.6, 2018, https://doi.org/10.1371/journal.pone.0233146
  33. Preventive Measures during Outbreak of Coronavirus Disease 2019 vol.95, pp.3, 2018, https://doi.org/10.3904/kjm.2020.95.3.134
  34. Ca2+ Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity vol.94, pp.13, 2018, https://doi.org/10.1128/jvi.00426-20
  35. The dynamics of entropy in the COVID-19 outbreaks vol.101, pp.3, 2020, https://doi.org/10.1007/s11071-020-05871-5
  36. What are the main patient safety concerns of healthcare stakeholders: a mixed-method study of Web-based text vol.140, pp.None, 2018, https://doi.org/10.1016/j.ijmedinf.2020.104162
  37. A numerical study of ventilation strategies for infection risk mitigation in general inpatient wards vol.13, pp.4, 2020, https://doi.org/10.1007/s12273-020-0623-4
  38. Face masks and containment of COVID-19: experience from South Korea vol.106, pp.1, 2018, https://doi.org/10.1016/j.jhin.2020.06.017
  39. HOME DIALYSIS DURING COVID-19 OUTBREAK- IT IS WORTH TO CONSIDER vol.73, pp.10, 2018, https://doi.org/10.36740/wlek202010141
  40. Current knowledge of COVID-19 and infection prevention and control strategies in healthcare settings: A global analysis vol.41, pp.10, 2020, https://doi.org/10.1017/ice.2020.237
  41. Assessment of adequacy of respiratory infection prevention in hospitals of Inner Mongolia, China: a cross-sectional study using unannounced standardized patients vol.132, pp.7, 2020, https://doi.org/10.1080/00325481.2020.1776015
  42. Prospective Diary Survey of Preschool Children's Social Contact Patterns: A Pilot Study vol.26, pp.4, 2018, https://doi.org/10.4094/chnr.2020.26.4.393
  43. COVID 19: challenges for virologists in the food industry vol.13, pp.6, 2018, https://doi.org/10.1111/1751-7915.13638
  44. SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations vol.31, pp.4, 2018, https://doi.org/10.1007/s13337-020-00632-9
  45. ECMO use in COVID-19: lessons from past respiratory virus outbreaks—a narrative review vol.24, pp.None, 2020, https://doi.org/10.1186/s13054-020-02979-3
  46. Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model vol.8, pp.4, 2018, https://doi.org/10.3390/vaccines8040634
  47. Practitioner experiences in epidemics and pandemics in relation to COVID-19 vol.10, pp.4, 2018, https://doi.org/10.12968/ippr.2020.10.4.79
  48. Understanding South Korea’s Response to the COVID-19 Outbreak: A Real-Time Analysis vol.17, pp.24, 2020, https://doi.org/10.3390/ijerph17249571
  49. Critical neurological features of COVID-19: Role of imaging methods and biosensors for effective diagnosis vol.2, pp.None, 2018, https://doi.org/10.1016/j.sintl.2021.100098
  50. Response to the COVID-19 Outbreak in The Emergency Department Designed for Emerging Infectious Diseases in Korea vol.53, pp.1, 2018, https://doi.org/10.3947/ic.2020.0143
  51. Care Process of Recanalization Therapy for Acute Stroke during the COVID-19 Outbreak in South Korea vol.17, pp.1, 2021, https://doi.org/10.3988/jcn.2021.17.1.63
  52. Viral pandemics in the past two decades: An overview vol.10, pp.8, 2018, https://doi.org/10.4103/jfmpc.jfmpc_2071_20
  53. Review of the role of big data and digital technologies in controlling COVID-19 in Asia: Public health interest vs. privacy vol.7, pp.None, 2018, https://doi.org/10.1177/20552076211002953
  54. Pediatric Emergency Department Utilization and Coronavirus Disease in Daegu, Korea vol.36, pp.1, 2021, https://doi.org/10.3346/jkms.2021.36.e11
  55. Human and novel coronavirus infections in children: a review vol.41, pp.1, 2018, https://doi.org/10.1080/20469047.2020.1781356
  56. The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects vol.14, pp.1, 2018, https://doi.org/10.14202/vetworld.2021.190-199
  57. Factors Affecting the Cases and Deaths of COVID-19 Victims vol.18, pp.2, 2018, https://doi.org/10.3390/ijerph18020674
  58. The Integration of Human and Veterinary Studies for Better Understanding and Management of Crimean-Congo Haemorrhagic Fever vol.12, pp.None, 2018, https://doi.org/10.3389/fimmu.2021.629636
  59. Altered Influenza Vaccination Coverage and Related Factors in Pregnant Women in Korea from 2007 to 2019 vol.36, pp.5, 2018, https://doi.org/10.3346/jkms.2021.36.e42
  60. Perspectives on Targeting IL-6 as a Potential Therapeutic Strategy for COVID-19 vol.41, pp.2, 2021, https://doi.org/10.1089/jir.2020.0135
  61. Behavioral responses to the 2015 MERS epidemic in Korea vol.41, pp.None, 2018, https://doi.org/10.1016/j.ehb.2020.100965
  62. Systematic assessment of South Korea’s capabilities to control COVID-19 vol.125, pp.5, 2021, https://doi.org/10.1016/j.healthpol.2021.02.011
  63. Multiplex PCR-Based Nanopore Sequencing and Epidemiological Surveillance of Hantaan orthohantavirus in Apodemus agrarius, Republic of Korea vol.13, pp.5, 2021, https://doi.org/10.3390/v13050847
  64. Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection vol.14, pp.6, 2021, https://doi.org/10.3390/ph14060511
  65. Middle East Respiratory Syndrome (MERS) Virus-Pathophysiological Axis and the Current Treatment Strategies vol.22, pp.5, 2018, https://doi.org/10.1208/s12249-021-02062-2
  66. Impact of Covid-19 on the Visit of Pediatric Patients with Injuries to the Emergency Department in Korea vol.8, pp.7, 2018, https://doi.org/10.3390/children8070568
  67. Knowledge, Perception, and Performance of Hand Hygiene and Their Correlation among Nursing Students in Republic of Korea vol.9, pp.7, 2018, https://doi.org/10.3390/healthcare9070913
  68. Ag-Based Synergistic Antimicrobial Composites. A Critical Review vol.11, pp.7, 2018, https://doi.org/10.3390/nano11071687
  69. Effective COVID-19 Control: A Comparative Analysis of the Stringency and Timeliness of Government Responses in Asia vol.18, pp.16, 2021, https://doi.org/10.3390/ijerph18168686
  70. After the pandemic: perspectives on the future trajectory of COVID-19 vol.596, pp.7873, 2018, https://doi.org/10.1038/s41586-021-03792-w
  71. A pilot study investigating the social contact patterns of Korean elderly vol.38, pp.5, 2018, https://doi.org/10.1111/phn.12884
  72. SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants vol.9, pp.1, 2021, https://doi.org/10.1128/spectrum.00261-21
  73. Interspecies Jumping of Bat Coronaviruses vol.13, pp.11, 2018, https://doi.org/10.3390/v13112188
  74. Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies vol.58, pp.8, 2018, https://doi.org/10.1080/10408363.2021.1944047
  75. COVID-19: Systemic risk and response management in the Republic of Korea vol.12, pp.None, 2018, https://doi.org/10.1016/j.pdisas.2021.100200
  76. Reduction in mobility and COVID-19 transmission vol.12, pp.1, 2018, https://doi.org/10.1038/s41467-021-21358-2
  77. Transmission dynamics and control measures of COVID-19 outbreak in China: a modelling study vol.11, pp.1, 2021, https://doi.org/10.1038/s41598-021-81985-z
  78. Experiences and Lessons Learned from COVID-19 Pandemic Management in South Korea and the V4 Countries vol.6, pp.4, 2021, https://doi.org/10.3390/tropicalmed6040201
  79. NGSocomial Infections: High-Resolution Views of Hospital-Acquired Infections Through Genomic Epidemiology vol.10, pp.suppl4, 2018, https://doi.org/10.1093/jpids/piab074